In all patients, serum CCL8 levels were significantly higher in those at CKD stage 3–5 (p = 0.049; Figure 1b) and those with a uPCR ≥ 1 group (p = 0.021; Figure 1c). The gene discussed is CCL8; the disease is chronic kidney disease.